The Full Range of US Software Startup Valuations in 2024

The Full Range of US Software Startup Valuations in 2024

Author

Peter Walker

|

Read time: 

1 minute

Published date: 

December 13, 2024

From the 10th percentile to bonkers at the 95th: seed through Series C valuations in 2024 show medians are robust but the upper end of the distribution is...

LinkedIn: The Full Range of US Software Startup Valuations in 2024

Founders - here's the full span of valuations for US software startups in 2024.

Obviously the headlines are full of figures from the right side of this table. Valuations at the 90th and 95th percentiles ("Wild" and "Bonkers", in the technical terms) are more likely to get press and Twitter plaudits.

𝗪𝗵𝗮𝘁 𝗦𝘁𝗮𝗻𝗱𝘀 𝗢𝘂𝘁

  • Median figures are quite robust - higher in basically every stage than they were last year and rivaling the peak values in early stages (though of course on lower round volume).

  • The Bonkers column looks like we never left 2021.

  • The Bonkers column is also full of AI startups.

  • The very low figures in 10th and 25th percentiles at Series D reflect some major down rounds over the past 12 months.

  • Unicorns are still being minted (67 new ones in the first 3 quarters of 2024).

  • Hardware and Biotech companies tend to lag on valuation in early stages but catch up in later ones.

  • Comparison remains the thief of joy!

Of course getting a Wild valuation in one round is no guarantee of anything in the next. Companies bounce around these percentiles all the time.

Just thought a full view would be more reassuring than the next Fortune headline figure 🙏

Here's to a healthy startup 2025!

#startups #valuations #founders #venturecapital

More data from Carta available every week to all who subscribe at the link in graphic.

Peter Walker
Author: Peter Walker
Peter Walker runs the Insights team at Carta, focused on discovering key data and narratives across the private capital ecosystem. In a former life, he was a marketing executive for a media analytics startup and led the data visualization team at the Covid Tracking Project.

DISCLOSURE: This communication is on behalf of eShares, Inc. dba Carta, Inc. ("Carta"). This communication is for informational purposes only, and contains general information only. Carta is not, by means of this communication, rendering accounting, business, financial, investment, legal, tax, or other professional advice or services. This publication is not a substitute for such professional advice or services nor should it be used as a basis for any decision or action that may affect your business or interests. Before making any decision or taking any action that may affect your business or interests, you should consult a qualified professional advisor. This communication is not intended as a recommendation, offer or solicitation for the purchase or sale of any security. Carta does not assume any liability for reliance on the information provided herein. © 2026 Carta. All rights reserved. Reproduction prohibited.